The Need for Standardization of Antiretinal Antibody Detection and Measurement

American Journal of Ophthalmology

Volumn 146, Issue 4, 2008, Pages 489-495

  Forooghian, Farzin ^a   MacDonald, Ian M ^a   Heckenlively, John R ^b   Héon, Elise ^c   Gordon, Lynn K ^d   Hooks, John J ^a   Detrick, Barbara ^e   Nussenblatt, Robert B ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d JULES STEIN EYE INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ALPHA ENOLASE ANTIBODY; AUTOANTIBODY; CARBONATE DEHYDRATASE II; HEAT SHOCK COGNATE PROTEIN 70; IMMUNOGLOBULIN ANTIBODY; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; RECOVERIN; RECOVERIN ANTIBODY; RETINA S ANTIGEN; TRANSDUCIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE RETINOPATHY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MEDICAL LITERATURE; MONITORING; PATHOGENESIS; PRIORITY JOURNAL; PUBLICATION; RETINA DEGENERATION; RETINOPATHY; STANDARDIZATION; WESTERN BLOTTING;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC TESTS; PHOSPHOPYRUVATE HYDRATASE; RECOVERIN; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL DISEASES;

EID: 51849123587     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.05.046     Document Type: Article

References (61)

1. Weleber R.G., Watzke R.C., Shults W.T., et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139 (2005) 780-794
2. Peek R., Verbraak F., Coevoet H.M., et al. Muller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci 39 (1998) 1976-1979
3. Weinstein J.M., Kelman S.E., Bresnick G.H., et al. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 101 (1994) 1236-1243
4. Jacobson D.M., Thirkill C.E., and Tipping S.J. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28 (1990) 162-167
5. Eltabbakh G.H., Hoogerland D.L., and Kay M.C. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol 58 (1995) 120-123
6. Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2 (2003) 63-68
7. Sawyer R.A., Selhorst J.B., Zimmerman L.E., et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81 (1976) 606-613
8. Mizener J.B., Kimura A.E., Adamus G., et al. Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 123 (1997) 607-618
9. Whitcup S.M., Vistica B.P., Milam A.H., et al. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126 (1998) 230-237
10. Thirkill C.E., Roth A.M., Takemoto D.J., et al. Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. Am J Ophthalmol 112 (1991) 132-137
11. Heckenlively J.R., Aptsiauri N., Nusinowitz S., et al. Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Trans Am Ophthalmol Soc 94 (1996) 179-200 discussion 200-206
12. Heckenlively J.R., Fawzi A.A., Oversier J., et al. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol 118 (2000) 1525-1533
13. Heckenlively J.R., Jordan B.L., and Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127 (1999) 565-573
14. Adamus G., Ren G., and Weleber R.G. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4 (2004) 5
15. Guy J., and Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117 (1999) 471-477
16. Thirkill C.E., Roth A.M., and Keltner J.L. Cancer-associated retinopathy. Arch Ophthalmol 105 (1987) 372-375
17. Keltner J.L., Thirkill C.E., Tyler N.K., et al. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110 (1992) 48-53
18. Ren G., and Adamus G. Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. J Autoimmun 23 (2004) 161-167
19. Adamus G., Aptsiauri N., Guy J., et al. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol 78 (1996) 120-129
20. Adamus G., Amundson D., Seigel G.M., et al. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun 11 (1998) 671-677
21. Kikuchi T., Arai J., Shibuki H., et al. Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol 103 (2000) 26-33
22. Chin M.S., Caruso R.C., Detrick B., et al. Autoantibodies to p75/LEDGF, a cell survival factor, found in patients with atypical retinal degeneration. J Autoimmun 27 (2006) 17-27
23. Potter M.J., Adamus G., Szabo S.M., et al. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134 (2002) 128-130
24. Ohguro H., Ogawa K., and Nakagawa T. Recoverin and Hsc70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 40 (1999) 82-89
25. Keltner J.L., and Thirkill C.E. The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol 19 (1999) 71-83
26. Ohkawa T., Kawashima H., Makino S., et al. Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol 122 (1996) 740-742
27. Espandar L., O'Brien S., Thirkill C., et al. Successful treatment of cancer-associated retinopathy with alemtuzumab. J Neurooncol 83 (2007) 295-302
28. Murphy M.A., Thirkill C.E., and Hart Jr. W.M. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol 17 (1997) 77-83
29. Masaoka N., Emoto Y., Sasaoka A., et al. Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina 19 (1999) 462-464
30. Keltner J.L., Roth A.M., and Chang R.S. Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 101 (1983) 564-569
31. Rizzo III J.F., and Gittinger Jr. J.W. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 99 (1992) 1286-1295
32. Thirkill C.E., Tait R.C., Tyler N.K., et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 33 (1992) 2768-2772
33. Thirkill C.E., Keltner J.L., Tyler N.K., et al. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 111 (1993) 931-937
34. Polans A.S., Burton M.D., Haley T.L., et al. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci 34 (1993) 81-90
35. Thirkill C.E., Tait R.C., Tyler N.K., et al. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. Arch Ophthalmol 111 (1993) 974-978
36. Polans A.S., Witkowska D., Haley T.L., et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A 92 (1995) 9176-9180
37. Goldstein S.M., Syed N.A., Milam A.H., et al. Cancer-associated retinopathy. Arch Ophthalmol 117 (1999) 1641-1645
38. Adamus G., Amundson D., MacKay C., et al. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol 116 (1998) 251-253
39. Ohguro H., Ogawa K., Maeda T., et al. Cancer-associated retinopathy induced by both anti-recoverin and anti-Hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 40 (1999) 3160-3167
40. Maeda T., Maeda A., Maruyama I., et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42 (2001) 705-712
41. Chen W., Elias R.V., Cao W., et al. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. J Neurosci Res 57 (1999) 706-718
42. Adamus G., Machnicki M., and Seigel G.M. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 38 (1997) 283-291
43. Adamus G., Machnicki M., Elerding H., et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 11 (1998) 523-533
44. Shiraga S., and Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132 (2002) 72-82
45. Adamus G., Webb S., Shiraga S., et al. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun 26 (2006) 146-153
46. Ohguro H., Ogawa K., Maeda T., et al. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Invest Ophthalmol Vis Sci 42 (2001) 2589-2595
47. McAleese S.M., Dunbar B., Fothergill J.E., et al. Complete amino acid sequence of the neurone-specific gamma isozyme of enolase (NSE) from human brain and comparison with the non-neuronal alpha form (NNE). Eur J Biochem 178 (1988) 413-417
48. He P., Naka T., Serada S., et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98 (2007) 1234-1240
49. Magrys A., Anekonda T., Ren G., et al. The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol 27 (2007) 181-192
50. Pratesi F., Moscato S., Sabbatini A., et al. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol 27 (2000) 109-115
51. Mosca M., Chimenti D., Pratesi F., et al. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 33 (2006) 695-697
52. Tang J., Stevens R.A., Okada A.A., et al. Association of antiretinal antibodies in acute annular outer retinopathy. Arch Ophthalmol 126 (2008) 130-132
53. Chan C.C., Palestine A.G., Nussenblatt R.B., et al. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 92 (1985) 1025-1028
54. Whittle R.M., Wallace G.R., Whiston R.A., et al. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82 (1998) 1017-1021
55. Chan C.C., Nussenblatt R.B., Kim M.K., et al. Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology 94 (1987) 439-443
56. Gurne D.H., Tso M.O., Edward D.P., et al. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 98 (1991) 602-607
57. Hooks J.J., Chin M.S., Chan C.C., and Detrick B. Monitoring autoimmune reactivity within the retina. In: Detrick B., Hamilton R.G., and Folds J.D. (Eds). Manual of Molecular and Clinical Laboratory Immunology (2006), ASM Press, Washington, DC 1136-1140
58. Forooghian F., Sproule M., Westall C., et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 113 (2006) 123-132
59. Shimazaki K., Jirawuthiworavong G.V., Heckenlively J.R., et al. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol 28 (2008) 5-11
60. Thirkill C.E., FitzGerald P., Sergott R.C., et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 321 (1989) 1589-1594
61. Mantel I., Ramchand K.V., Holder G.E., et al. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology. Exp Mol Pathol 84 (2008) 90-101